Shortage of Chemotherapy Drugs Brings Rationing Fears

The New York Times examines the growing shortage of several essential generic chemotherapy drugs and the challenges hospitals face in maintaining access to lifesaving cancer treatments. The article cites data from Premier, shared by Amanda Forster, vice president of integrated communications at Premier, illustrating the extent of supply constraints for key chemotherapy medications such as ifosfamide and cisplatin. The piece also explores how providers are adapting treatment strategies while manufacturers and federal agencies work to stabilize supply.

Read the full story on The New York Times.